Immune Biomarkers in Personalising Treatments

Substantial progress in molecular immunology, coupled with an increasing focus on translational research and an enthusiasm for personalised medicine, has resulted in a rapid expansion in the field of immune biomarkers in recent years. Through this event we will hear from research pioneers in inflammatory diseases and malignancies and their approaches in applying immune biomarkers and translating findings into clinical use.

Speakers

13.00-13.05 Welcome Introduction: Prof Hans Stauss, UCL Royal Free Hospital

13.05- 13.35 Prof Lucy Wedderburn UCL GOS Institute of Child Health, CLUSTER

13.35-14.05 Dr Martin Pule, UCL CI, founder of Autolus

14.05- 14.35 Dr Kiran Nistala, VP Clinical Immunology, AstraZeneca.

14.35- 15.05 Prof Sergio Quezada, UCL CI, Co-founder of Achilles Therapeutics

15.05- 15.20 Panel Discussion

The link to Teams will be sent two days before the event. For more information, please contact Dr Mali Eskandarpour, m.eskandarpour@ucl.ac.uk

Main image: Wiki Commons